Efficacy and Safety of Topical Bromfenac Ophthalmic Solution vs. Placebo in Subjects With Allergic Conjunctivitis

Completed · Phase 3 · Has a placebo group

Conditions studied: Allergic Conjunctivitis

In brief

The primary objective of this study is to investigate the efficacy and safety of bromfenac ophthalmic solution for treatment in subjects with a history of allergic conjunctivitis

Key facts

Study ID

NCT00423007

Run by

Bausch & Lomb Incorporated

People needed

90

Starts

2006-11-01

Expected to finish

2007-08-01

Last updated by the study team

2013-03-14

Who can join

Age: 10 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• History of clinically active allergic conjunctivitis
• Agree to return for all required visits
• Agree to avoid disallowed meds

You may not qualify if…

• Known hypersensitivity to bromfenac and salicylates

Where it is running

• ISTA Pharmaceuticals, Inc. — Irvine, California, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.